News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
232,172 Results
Type
Article (5097)
Company Profile (24)
Press Release (227051)
Multimedia
Podcasts (2)
Webinars (4)
Section
Business (82314)
Career Advice (463)
Deals (15066)
Drug Delivery (8)
Drug Development (19080)
Employer Resources (30)
FDA (3687)
Job Trends (3911)
News (120273)
Policy (7519)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (293)
Accelerated approval (6)
Adcomms (4)
Allergies (15)
Alliances (14808)
ALS (38)
Alzheimer's disease (294)
Antibody-drug conjugate (ADC) (40)
Approvals (3788)
Artificial intelligence (80)
Autoimmune disease (27)
Automation (5)
Bankruptcy (97)
Best Places to Work (2866)
Biosimilars (32)
Biotechnology (23)
Bladder cancer (34)
Brain cancer (7)
Breast cancer (101)
Cancer (887)
Cardiovascular disease (61)
Career advice (395)
Career pathing (3)
CAR-T (64)
CDC (2)
Cell therapy (166)
Cervical cancer (5)
Clinical research (16686)
Collaboration (353)
Compensation (371)
Complete response letters (8)
COVID-19 (313)
CRISPR (13)
C-suite (339)
Cystic fibrosis (28)
Data (1325)
Denatured (1)
Depression (21)
Diabetes (78)
Diagnostics (2115)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (31)
Drug pricing (14)
Drug shortages (2)
Duchenne muscular dystrophy (35)
Earnings (42759)
Editorial (5)
Employer branding (6)
Employer resources (32)
Events (39140)
Executive appointments (425)
FDA (4427)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (343)
Gene editing (24)
Generative AI (5)
Gene therapy (102)
GLP-1 (144)
Government (423)
Guidances (197)
Healthcare (5046)
HIV (10)
Huntington's disease (5)
IgA nephropathy (11)
Immunology and inflammation (39)
Immuno-oncology (7)
Indications (16)
Infectious disease (339)
Inflammatory bowel disease (36)
Inflation Reduction Act (3)
Influenza (6)
Intellectual property (32)
Interviews (53)
IPO (7880)
IRA (3)
Job creations (1123)
Job search strategy (361)
JPM (4)
Kidney cancer (10)
Labor market (10)
Layoffs (106)
Leadership (5)
Legal (2340)
Liver cancer (21)
Longevity (2)
Lung cancer (92)
Lymphoma (70)
Machine learning (3)
Management (10)
Manufacturing (140)
MASH (50)
Medical device (3938)
Medtech (3948)
Mergers & acquisitions (7591)
Metabolic disorders (214)
Multiple sclerosis (18)
NASH (6)
Neurodegenerative disease (54)
Neuropsychiatric disorders (12)
Neuroscience (539)
NextGen: Class of 2026 (1675)
Non-profit (730)
Now hiring (5)
Obesity (84)
Opinion (32)
Ovarian cancer (26)
Pain (26)
Pancreatic cancer (38)
Parkinson's disease (50)
Partnered (6)
Patents (51)
Patient recruitment (96)
Peanut (6)
People (25265)
Pharmaceutical (7)
Pharmacy benefit managers (2)
Phase 1 (4995)
Phase 2 (7227)
Phase 3 (5789)
Pipeline (1962)
Policy (17)
Postmarket research (625)
Preclinical (1947)
Press Release (66)
Prostate cancer (57)
Psychedelics (3)
Radiopharmaceuticals (109)
Rare diseases (179)
Real estate (1887)
Recruiting (8)
Regulatory (5539)
Reports (17)
Research institute (308)
Resumes & cover letters (69)
Rett syndrome (19)
RNA editing (1)
RSV (2)
Schizophrenia (49)
Series A (53)
Series B (55)
Sickle cell disease (10)
Special edition (1)
Spinal muscular atrophy (33)
Sponsored (5)
Startups (1018)
Stomach cancer (1)
Supply chain (13)
Tariffs (7)
The Weekly (1)
Vaccines (80)
Venture capital (9)
Weight loss (29)
Women's health (6)
Date
Today (4)
Last 7 days (147)
Last 30 days (608)
Last 365 days (8910)
2026 (785)
2025 (9040)
2024 (11039)
2023 (13203)
2022 (18676)
2021 (19686)
2020 (18241)
2019 (13209)
2018 (10212)
2017 (10013)
2016 (9166)
2015 (12131)
2014 (9590)
2013 (7719)
2012 (8333)
2011 (8802)
2010 (8650)
Location
Africa (186)
Alabama (19)
Alaska (2)
Arizona (74)
Arkansas (1)
Asia (11785)
Australia (1691)
California (3544)
Canada (1138)
China (167)
Colorado (143)
Connecticut (162)
Delaware (70)
Europe (25519)
Florida (543)
Georgia (67)
Idaho (24)
Illinois (161)
India (14)
Indiana (105)
Iowa (9)
Japan (164)
Kansas (36)
Kentucky (17)
Louisiana (8)
Maine (51)
Maryland (353)
Massachusetts (2803)
Michigan (104)
Minnesota (203)
Mississippi (1)
Missouri (31)
Montana (17)
Nebraska (12)
Nevada (46)
New Hampshire (16)
New Jersey (1019)
New Mexico (5)
New York (814)
North Carolina (479)
North Dakota (4)
Northern California (1856)
Ohio (116)
Oklahoma (5)
Oregon (6)
Pennsylvania (597)
Puerto Rico (1)
Rhode Island (19)
South America (279)
South Carolina (17)
Southern California (1304)
Tennessee (61)
Texas (480)
United States (12337)
Utah (111)
Virginia (84)
Washington D.C. (17)
Washington State (297)
West Virginia (2)
Wisconsin (57)
Wyoming (1)
232,172 Results for "cordis corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cordis to Unveil 12-Month Results from Two SELUTION SLR™ DEB Randomized Clinical Trials at TCT 2025 Late-Breaking Clinical Trials Session
October 22, 2025
·
3 min read
Press Releases
Cordis Unveiled Breakthrough Results from SELUTION DeNovo and SELUTION4ISR Randomized Trials at TCT 2025, Transforming Coronary Artery Disease (CAD) Treatment Beyond Stenting
October 27, 2025
·
4 min read
BioMidwest
Cordis Announces Scott Drake as Chief Executive Officer
Cordis announced that its Board of Directors has appointed Scott Drake as Chief Executive Officer effective immediately.
November 6, 2023
·
2 min read
Cordis Announces Positive 24-Month Results from Superficial Femoral Artery Study, Confirming Sustained Benefits of SELUTION SLR™ (sustained limus release) Drug-Eluting Balloon in Complex Patients
Cordis, a global leader in the development and manufacturing of interventional cardiovascular and endovascular technology, today announces positive 24-month results from the SELUTION SFA Japan Trial.
June 18, 2024
·
3 min read
Deals
Cordis Announces the Completed Acquisition of MedAlliance
Cordis, a worldwide leader in the development and manufacturing of interventional cardiovascular and endovascular technology, announced that it has completed the acquisition of MedAlliance, a Switzerland-based developer of drug-eluting balloon technology.
October 2, 2023
·
3 min read
Press Releases
Cordis Announces Positive Results from Two Major Studies Demonstrating Durable Efficacy of SELUTION SLR™ Drug-Eluting Balloon in Complex Peripheral Artery Disease Patients
April 25, 2025
·
3 min read
BioMidwest
Cordis issues statement on the CMS announcement to expand coverage of carotid stenting
Cordis, a worldwide leader in the development and manufacturing of interventional cardiovascular and endovascular technology, strongly supports the decision made by the Centers for Medicare & Medicaid Services to expand coverage of carotid artery stenting cms.gov.
October 16, 2023
·
2 min read
Cordis announces the completion of patient enrollment in SELUTION SLR™ SUCCESS PTA Study
Cordis has announced completion of patient enrollment in SUCCESS PTA, its large post-market study with the SELUTION SLR™ Drug-Eluting Balloon (DEB) for the treatment of patients with peripheral artery disease (PAD).
October 24, 2023
·
4 min read
News
Cordis receives FDA approval for MYNX CONTROL™ VENOUS Vascular Closure Device
July 9, 2024
·
2 min read
Press Releases
Lyra Therapeutics Provides Corporate Update
January 12, 2026
·
4 min read
1 of 23,218
Next
